Sylvia Van Den Hurk

Title: Innovations and Contributions of Sylvia Van Den Hurk

Introduction

Sylvia Van Den Hurk is a prominent inventor based in Saskatoon, Canada. She has made significant contributions to the field of immunology, particularly in the development of vaccines and immune response enhancement methods. With a total of 4 patents, her work has had a substantial impact on the treatment and prevention of microbial infections.

Latest Patents

One of her latest patents is focused on a combination adjuvant formulation. This patent describes methods and compositions for enhancing an immune response to a selected antigen. The methods are particularly useful for treating and preventing microbial infections caused by bacteria, viruses, fungi, and parasites. The compositions include host defense peptides, polyphosphazenes, and immunostimulatory sequences to enhance the immune response to a coadministered antigen. Another notable patent involves recombinant bovine herpesvirus type 1 polypeptides and immunoassays. This patent provides recombinant subunit vaccines against bovine herpesvirus type 1 (BHV-1), along with methods of vaccination and the recombinant production of subunit antigens or nucleotide sequences used in the vaccines.

Career Highlights

Sylvia has worked at the University of Saskatchewan, where she has contributed to various research projects and initiatives. Her work has been instrumental in advancing the understanding of immune responses and vaccine development.

Collaborations

Throughout her career, Sylvia has collaborated with notable individuals such as Lorne A Babiuk and Tim Zamb. These collaborations have further enriched her research and innovations in the field.

Conclusion

Sylvia Van Den Hurk's contributions to immunology and vaccine development are noteworthy. Her innovative patents and collaborations highlight her dedication to enhancing public health through scientific research.